Army Drug Development Program. Phase 1. Clinical Testing.
Abstract
This is the final report of contract DAMD17-83-C-3001 under which BIO-MED, Inc. was involved in the following activities: The development of protocols for Phase I Clinical Studies and the administrative and technical processing of these protocols. Analysis, interpretation and reporting of the results of studies. Keywords: Pharmacokinetics, Anti-Malarials, Pyridostigmine, Abate, WR 194,965, Acetylcholinesterase Assays, WR 6026.
Document Details
- Document Type
- Technical Report
- Publication Date
- Apr 01, 1985
- Accession Number
- ADA188226
Entities
People
- Kevin G. Barry
- Richard C. Reba